Yield10 Bioscience, Inc.

NASDAQ

Market Cap.

345.46K

Avg. Volume

5.09K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Yield10 Bioscience, Inc.

Yield10 Bioscience, Inc. News

Yield10 Bioscience, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
Basic MaterialsAgricultural Inputs
yield10bio.com

About Yield10 Bioscience, Inc.

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.

Yield10 Bioscience, Inc. Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Yield10 Bioscience, Inc. Financials

Table Compare

Compare YTEN metrics with:

   

Earnings & Growth

YTEN

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

YTEN

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

YTEN

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

YTEN

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Yield10 Bioscience, Inc. Income

Yield10 Bioscience, Inc. Balance Sheet

Yield10 Bioscience, Inc. Cash Flow

Yield10 Bioscience, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Sell
Return on EquityStrong Buy
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Yield10 Bioscience, Inc. Executives

NameRole
Dr. Oliver P. Peoples Ph.D.Co-Founder, President, Chief Executive Officer & Director
Ms. Lynne H. BrumVice President of Planning & Corporate Communications and Secretary
Mr. Charles B. Haaser CPAVice President of Finance, Chief Accounting Officer & Treasurer
NameRoleGenderDate of BirthPay
Dr. Oliver P. Peoples Ph.D.Co-Founder, President, Chief Executive Officer & Director1958358.39K
Ms. Lynne H. BrumVice President of Planning & Corporate Communications and SecretaryFemale1964287.14K
Mr. Charles B. Haaser CPAVice President of Finance, Chief Accounting Officer & TreasurerMale1956236.41K

Yield10 Bioscience, Inc. Insider Trades

Date15 Aug
NameSnell Kristi
RoleVP Research and CSO
TransactionDisposed
TypeF-InKind
Shares877
Date15 Aug
NameBRUM LYNNE H
RoleVP Planning and Communications
TransactionDisposed
TypeF-InKind
Shares731
Date15 Aug
NameHAASER CHARLES B
RoleVP Finance and CAO
TransactionDisposed
TypeF-InKind
Shares731
Date15 Aug
NamePeoples Oliver P
RolePresident and CEO
TransactionDisposed
TypeF-InKind
Shares1463
Date20 Dec
NameSCHULER JACK W
Role10 percent owner
TransactionDisposed
TypeS-Sale
Shares36000
DateNameRoleTransactionTypeShares
15 AugSnell KristiVP Research and CSODisposedF-InKind877
15 AugBRUM LYNNE HVP Planning and CommunicationsDisposedF-InKind731
15 AugHAASER CHARLES BVP Finance and CAODisposedF-InKind731
15 AugPeoples Oliver PPresident and CEODisposedF-InKind1463
20 DecSCHULER JACK W10 percent ownerDisposedS-Sale36000

Discover More

Streamlined Academy

Yield10 Bioscience, Inc.

NASDAQ

Market Cap.

345.46K

Avg. Volume

5.09K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Yield10 Bioscience, Inc. News

Yield10 Bioscience, Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Yield10 Bioscience, Inc. Earnings & Revenue

Yield10 Bioscience, Inc. Income

Yield10 Bioscience, Inc. Balance Sheet

Yield10 Bioscience, Inc. Cash Flow

Yield10 Bioscience, Inc. Financials Over Time

Yield10 Bioscience, Inc. Executives

NameRole
Dr. Oliver P. Peoples Ph.D.Co-Founder, President, Chief Executive Officer & Director
Ms. Lynne H. BrumVice President of Planning & Corporate Communications and Secretary
Mr. Charles B. Haaser CPAVice President of Finance, Chief Accounting Officer & Treasurer
NameRoleGenderDate of BirthPay
Dr. Oliver P. Peoples Ph.D.Co-Founder, President, Chief Executive Officer & Director1958358.39K
Ms. Lynne H. BrumVice President of Planning & Corporate Communications and SecretaryFemale1964287.14K
Mr. Charles B. Haaser CPAVice President of Finance, Chief Accounting Officer & TreasurerMale1956236.41K

Yield10 Bioscience, Inc. Insider Trades

Date15 Aug
NameSnell Kristi
RoleVP Research and CSO
TransactionDisposed
TypeF-InKind
Shares877
Date15 Aug
NameBRUM LYNNE H
RoleVP Planning and Communications
TransactionDisposed
TypeF-InKind
Shares731
Date15 Aug
NameHAASER CHARLES B
RoleVP Finance and CAO
TransactionDisposed
TypeF-InKind
Shares731
Date15 Aug
NamePeoples Oliver P
RolePresident and CEO
TransactionDisposed
TypeF-InKind
Shares1463
Date20 Dec
NameSCHULER JACK W
Role10 percent owner
TransactionDisposed
TypeS-Sale
Shares36000
DateNameRoleTransactionTypeShares
15 AugSnell KristiVP Research and CSODisposedF-InKind877
15 AugBRUM LYNNE HVP Planning and CommunicationsDisposedF-InKind731
15 AugHAASER CHARLES BVP Finance and CAODisposedF-InKind731
15 AugPeoples Oliver PPresident and CEODisposedF-InKind1463
20 DecSCHULER JACK W10 percent ownerDisposedS-Sale36000

Streamlined Academy

Website screenshot
Basic MaterialsAgricultural Inputs
yield10bio.com

About Yield10 Bioscience, Inc.

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Yield10 Bioscience, Inc.

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Yield10 Bioscience, Inc. Financials

Table Compare

Compare YTEN metrics with:

   

Earnings & Growth

YTEN

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

YTEN

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

YTEN

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

YTEN

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Sell
Return on EquityStrong Buy
Return on AssetsStrong Sell
Debt/Equity RatioStrong Sell
Price/Earnings RatioStrong Sell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)